Facebook
RSS
Twitter
Home
Politics
Office of the Calif. Governor
Ballots and Bills
Economic Development
Articles: POLITICAL OPINION
Business
Finance
NonProfit
Entertainment
Tech
Articles
Articles: ENTERTAINMENT
Articles: LIFESTYLE
[ARCHIVE]: Political Opinion
National
Search
Sun, Sep 7, 2025
About California Newswire
About our Staff
Terms of Use
Contact Us
Privacy Statement
RSS Feeds
Submit News
Facebook
RSS
Twitter
California Newswire
Home
Politics
Office of the Calif. Governor
Ballots and Bills
Economic Development
Articles: POLITICAL OPINION
Business
Finance
NonProfit
Entertainment
Tech
Articles
Articles: ENTERTAINMENT
Articles: LIFESTYLE
[ARCHIVE]: Political Opinion
National
Home
City: San Marino
City: San Marino
San Marino News – business, entertainment and technology news from San Marino, California
Advanced Phase I and Phase II Studies of Targeted Gene Delivery Confirm That Rexin-G Impacts Survival in Chemotherapy-resistant Bone and Soft...
Cindy Holden
-
Jun 1, 2010
FDA Fast Track Designation for the Treatment of Pancreatic Cancer Given to Rexin-G®
Valerie Gotten
-
Jun 19, 2009
Rexin-G® Nano Particles Target Metastatic Cancers
Cindy Holden
-
Jun 15, 2009
Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma
Valerie Gotten
-
May 18, 2009
Beginners Luck, or Creative Artists of the First Rank? Epeius Bio Launches Rexin-G eBook Tutorial
Cindy Holden
-
Feb 13, 2009
Rexin-G® Shrinks Metastatic Tumors and Triples Survival Time in Chemotherapy-Resistant Pancreatic Cancer
Cindy Holden
-
Jan 20, 2009
Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine
Cindy Holden
-
Dec 16, 2008
Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma
Cindy Holden
-
Nov 21, 2008
Epeius Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
Cindy Holden
-
Oct 30, 2008
Epeius Biotech Reveals a New Generation of Tools for Medical Gene Delivery
Cindy Holden
-
Oct 6, 2008
Rexin-G for Metastatic Cancer Aptly Highlighted by National Cancer Institute Journal
Cindy Holden
-
Sep 15, 2008
FDA Grants Rexin-G from Epeius Biotechnologies a Third Orphan Drug Designation
Cindy Holden
-
Jul 11, 2008
Epeius Biotechnologies’ Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for Osteosarcoma Treatment
Cindy Holden
-
Jul 8, 2008
IV Infusions of Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity
Cindy Holden
-
May 29, 2008
Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes
Cindy Holden
-
May 27, 2008
Rexin-G Monotherapy Reveals Significant Biological Activity without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
Cindy Holden
-
May 22, 2008
ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity without Toxicity in Metastatic Pancreatic Cancer
Cindy Holden
-
May 19, 2008
Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy
Cindy Holden
-
Apr 21, 2008
Epeius Bio Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
Cindy Holden
-
Mar 25, 2008
As Targeted Gene Therapy Comes of Age in Clinical Medicine, Epeius Biotechnologies Applauds Their Academic Contemporaries
Valerie Gotten
-
Dec 18, 2007
ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
Cindy Holden
-
Dec 18, 2007
FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G for Osteosarcoma
Cindy Holden
-
Nov 5, 2007
Epeius Biotechnologies Leads with Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference...
Cindy Holden
-
Oct 18, 2007
California Biotech Company Takes Aim at Pancreatic Cancer With an Advanced Phase I/II Clinical Trial
Cindy Holden
-
Jul 12, 2007
Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
Valerie Gotten
-
Jun 5, 2007
Epeius Biotechnologies Gains FDA Approval for Two New Clinical Trials Using Rexin-G(TM) for Breast Cancer and Sarcoma
Valerie Gotten
-
Jun 4, 2007
Epeius Biotechnologies to Present the Advent of Tumor Targeting Technology at C21 BioVentures Conference
Cindy Holden
-
May 15, 2007
Japanese Study Confirms Safety and Efficacy of Intravenous Rexin-G
Cindy Holden
-
Dec 6, 2006
Rexin-G, The World’s First Tumor-Targeted Gene Therapy Vector, Stymies Metastatic Cancer
Valerie Gotten
-
Dec 4, 2006
FEATURED NEWS
The Light Committee is First L.A.-based Headshot Photography Studio to Earn 500 Five-Star Reviews
Sep 5, 2025
Culver City Jazz Nights 2025 come to the Kirk Douglas Theatre in September
Sep 3, 2025
LA Metro Reinforces ‘Safety Begins with You’ Rail Safety Advice During 2025 Rail Safety Month
Sep 3, 2025
Aztec Link Vodka Launches to Support SDSU Student-Athletes, Help Fund NIL Opportunities
Aug 28, 2025
Energuy and Finturf Launch Incentive Program for Contractors, for Every Financed Project Using Energuy Services
Aug 28, 2025